000089592 001__ 89592
000089592 005__ 20210902121640.0
000089592 0247_ $$2doi$$a10.2340/00015555-3409
000089592 0248_ $$2sideral$$a117623
000089592 037__ $$aART-2020-117623
000089592 041__ $$aeng
000089592 100__ $$aAltunay, I.K.
000089592 245__ $$aPsychosocial Aspects of Adult Acne: Data from 13 European Countries
000089592 260__ $$c2020
000089592 5060_ $$aAccess copy available to the general public$$fUnrestricted
000089592 5203_ $$aThe link between acne and psychiatric morbidities has been demonstrated in many studies; however, large scale studies aiming to reveal the psychosocial impact of acne are rare. The aim of this study was to assess the psychological burden of adult acne patients. This analysis was based on a multicenter study including 213 acne patients and 213 controls from 13 European countries. The Hospital Anxiety and Depression Scale (HADS), Dermatology Life Quality Index, and EuroQol 5 dimensions 3 levels scores of the patients with acne were analyzed. Patients with acne (n = 213) had higher HADS scores for anxiety (mean +/- standard deviation 6.70 +/- 3.84) and depression (3.91 +/- 3.43) than the controls (p < 0.001 for both). For patients with acne, 40.6% reported that they were very concerned about their skin disease, 12.3% had suicidal ideation, and, among those, 10 (4%) patients implied that acne was the cause of their suicidal thoughts. After adjusting for other variables, patients who had suicidal ideation (p = 0.007, and adjusted odds ratio 3.32 [95% confidence interval (CI): 1.39-7.93]) and stressful life events (p < 0.001, and adjusted OR 5.85 [95% CI: 2.65-12.86]) had a greater chance of fulfilling the HADS criteria for anxiety. This study highlights the need for a psychotherapeutic approach in order to recognize the concerns of acne patients and optimize their treatment.
000089592 540__ $$9info:eu-repo/semantics/openAccess$$aby-nc$$uhttp://creativecommons.org/licenses/by-nc/3.0/es/
000089592 590__ $$a4.437$$b2020
000089592 591__ $$aDERMATOLOGY$$b15 / 68 = 0.221$$c2020$$dQ1$$eT1
000089592 592__ $$a0.981$$b2020
000089592 593__ $$aMedicine (miscellaneous)$$c2020$$dQ1
000089592 593__ $$aDermatology$$c2020$$dQ1
000089592 655_4 $$ainfo:eu-repo/semantics/article$$vinfo:eu-repo/semantics/publishedVersion
000089592 700__ $$aOzkur, E.
000089592 700__ $$aDalgard, F.J.
000089592 700__ $$aGieler, U.
000089592 700__ $$0(orcid)0000-0003-1917-6906$$aTomas-Aragones, L.$$uUniversidad de Zaragoza
000089592 700__ $$aLien, L.
000089592 700__ $$aPoot, F.
000089592 700__ $$aJemec, G.B.E.
000089592 700__ $$aMisery, L.
000089592 700__ $$aSzabo, C.
000089592 700__ $$aLinder, D.
000089592 700__ $$aSampogna, F.
000089592 700__ $$aEvers, A.W.M.
000089592 700__ $$aHalvorsen, J.A.
000089592 700__ $$aBalieva, F.
000089592 700__ $$aSzepietowski, J.
000089592 700__ $$aRomanov, D.
000089592 700__ $$0(orcid)0000-0001-5632-0351$$aMarron, S.E.$$uUniversidad de Zaragoza
000089592 700__ $$aFinlay, A.Y.
000089592 700__ $$aSalek, S.S.
000089592 700__ $$aKupfer, J.
000089592 7102_ $$14009$$2735$$aUniversidad de Zaragoza$$bDpto. Psicología y Sociología$$cÁrea Psicolog.Evolut.Educac
000089592 7102_ $$11007$$2183$$aUniversidad de Zaragoza$$bDpto. Medicina, Psiqu. y Derm.$$cÁrea Dermatología
000089592 773__ $$g100, 2 (2020), adv00051 [6 pp]$$pActa derm.-venereol.$$tACTA DERMATO-VENEREOLOGICA$$x0001-5555
000089592 8564_ $$s215253$$uhttps://zaguan.unizar.es/record/89592/files/texto_completo.pdf$$yVersión publicada
000089592 8564_ $$s705308$$uhttps://zaguan.unizar.es/record/89592/files/texto_completo.jpg?subformat=icon$$xicon$$yVersión publicada
000089592 909CO $$ooai:zaguan.unizar.es:89592$$particulos$$pdriver
000089592 951__ $$a2021-09-02-08:59:50
000089592 980__ $$aARTICLE